BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Cell Therapy
    • COVID-19
    • CAR-T
    • Cord Blood
  • Exosomes
  • Interviews
  • News
    • Press Releases
    • Job Posts
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » Products » Database of U.S. FDA RMAT Designations (50)
Sale!
RMAT Designation

Database of U.S. FDA RMAT Designations (50)

Category: Stem Cells Tag: RMAT
  • Description

Description

The world’s only searchable, sortable database of RMAT designations that is continuously updated.

To date, 50 RMAT designations have been publicly announced. However, the FDA states it has received 155 requests and issued 59, which means that several are not yet public knowledge.

Discover class-defining bioproduction tools.

Only two companies have received multiple RMATs from the U.S. FDA, which are Abeona Therapeutics and Athersys.

RMAT stands for “Regenerative Medicine Advanced Therapy” designation. Sponsors of cell and gene therapies are eligible to obtain an RMAT designation from the U.S. FDA if their product is intended to treat serious or life-threatening diseases and there is preliminary clinical evidence that it can address unmet medical needs.

While cell and gene therapies have been the most common recipients of RMAT awards, tissue engineering and combination products have also received them.

RMAT Designations

Since the RMAT designation was introduced in 2017, BioInformant’s team of analysts have maintained a searchable, sortable database of every approval.  

It was originally developed in-house for our own purposes, but we had more and more clients requesting access to it.

The database presents all known RMAT recipients, including:

  • Company Name
  • Product Name
  • Medical Indication
  • Date of Approval
  • Product Category (Cell Therapy, Gene Therapy, Tissue or Combination Product)
  • Company Website
  • Link to RMAT Announcement

Because RMAT designations allow for faster, more streamlined approvals of regenerative medicine products within the U.S., this database reveals the identities of 49 of the most innovative competitors within the marketplace.

In addition to identifying products under development and the conditions they treat, the database is searchable and sortable, allowing you to assess the rate of increase in RMAT designations over time.

Because it is an essential resource within our company, we’re confident it will be a valuable resource for you too.

For a brief time, you can claim this comprehensive RMAT Database for only $37 (25% off).

Act now, before this offer expires and receive this database instantly as an Excel download.

Of course, your investment is backed by a Greater than 100% Money Back Guarantee.

4.9 / 5 ( 79 votes )

$49 $37

Related products

  • COVID-19 Coronavirus Market Report

    COVID-19 Global Market: Cell Therapies, Diagnostics, Treatments, Vaccines

    $3,495 – $4,497
    Select options
  • Consulting with Cade Hildreth

    Stem Cell Industry Consulting – Speak with Cade Hildreth, Founder/President

    $449 – $597
    Select options
  • Stem Cell Fact Sheet – Types of Stem Cells and their Use in Medicine

    $10
    Add to cart
  • Sale!

    Cell Therapy Manufacturing Survey – Selection Criteria for Choosing a CMO Partner

    $197 $97
    Add to cart

Let’s Get Social

  • Facebook
  • Twitter
  • Instagram
  • Pinterest
  • LinkedIn

Nanocellect

Marathon Products

Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Top Rated Products

  • US Cord Blood and Cord Tissue Storage Rates Rates of U.S. Cord Blood and Cord Tissue Storage - Historical and Projected
    Rated 0 out of 5
    $197
  • Job Posting on BioInformant Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience
    Rated 0 out of 5
    $297
  • BioInformant Audience Reach BioInformant's Audience with Your Press Announcement
    Rated 0 out of 5
    $397 $297
My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2021 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: [email protected] | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.